Skip to main content
Fig. 5 | Arthritis Research & Therapy

Fig. 5

From: TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis

Fig. 5

Following Anbainuo treatment, some T cell and B cell subtypes displayed significant changes. We compared in 55 HCs and 23 Anbainuo-treated AS patients. Anbainuo, recombinant human tumor necrosis factor-α receptor II: IgG Fc fusion protein for injection, made in China. P value summary: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Treg cell, regulatory T cell; Tc cell, cytotoxic T lymphocyte; Tfh cell, follicular helper T cell; B10 cell, IL-10 producing regulatory B cell

Back to article page